MedTrace Logo

Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19

NCT04551339 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2700

Last updated 2021-08-10

No results posted yet for this study

Summary

The purpose of this research study is to look at high dose zinc versus multivitamin micronutrient supplementation to support immune health in the setting of the COVID-19 pandemic.

Conditions

  • Healthy
  • Health Care Worker Patient Transmission
  • Aging

Interventions

DIETARY_SUPPLEMENT

PreserVision AREDS formulation soft gels or tablets

Two tabs taken daily for three months

DIETARY_SUPPLEMENT

Multivitamin with 11mg of zinc

One tab taken daily for three months

Sponsors & Collaborators

Principal Investigators

  • Atta Behfar, MD, PhD · Mayo Clinic

  • Albert Hakaim, MD · Mayo Clinic

  • Ayan Sen, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-28
Primary Completion
2021-05-28
Completion
2021-05-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04551339 on ClinicalTrials.gov